Stocks
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -361.3 | 308.7 | -642.0 | -537.5 | -474.6 | -434.6 | ||
| Changes by years, y/y, % | +53% | -185% | -308% | -16% | -12% | +14.9% | |||
Blueprint Medicines Corporation. EBITDA US GAAP, bln rub
Blueprint Medicines Corporation. EBITDA US GAAP, changes, %
Blueprint Medicines Corporation. EBITDA US GAAP, sum by quarters, bln rub
Blueprint Medicines Corporation (BPMC) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -123.2 | -128.0 | -129.0 | -103.6 | -74.0 | -434.6 | |
| Changes by years, y/y, % | +18% | -18% | +5% | -31% | -40% | |||
| Changes by quarters, q/q, % | -18% | +4% | +1% | -20% | -29% | |||
